Abstract
Humans are capable of sensing five basic tastes and of these, bitter taste sensation alone, is mediated by a large group of 25 cell surface proteins known as, bitter taste receptors (T2Rs). T2Rs belong to the G-protein coupled receptor (GPCR) superfamily. However, they share little homology with the large subfamily of Class A GPCRs. Very little progress has been made in understanding the dynamics of T2R activation, and in discovery of molecules that can block (bitter blockers) T2R activation. Only recently few structure-function studies focused on elucidating the ligand binding mechanisms of T2Rs have been published. Here we will discuss the roles of conserved amino acids in T2R structure-function, possible mechanisms of activation of T2Rs, and compare and contrast with the recent crystal structures of the Class A GPCRs.
Keywords: G-protein coupled receptors (GPCRs), bitter taste receptors (T2Rs), structure-function analysis, T2R heterologous expression, T2R ligand binding, T2R receptor activation mechanism(s), bitter blockers, receptor-expressing cells, Extra-Oral Tissues, GPCRs
Current Protein & Peptide Science
Title:Recent Advances in Structure and Function Studies on Human Bitter Taste Receptors
Volume: 13 Issue: 6
Author(s): Sai Prasad Pydi, Jasbir Upadhyaya, Nisha Singh, Rajinder Pal Bhullar and Prashen Chelikani
Affiliation:
Keywords: G-protein coupled receptors (GPCRs), bitter taste receptors (T2Rs), structure-function analysis, T2R heterologous expression, T2R ligand binding, T2R receptor activation mechanism(s), bitter blockers, receptor-expressing cells, Extra-Oral Tissues, GPCRs
Abstract: Humans are capable of sensing five basic tastes and of these, bitter taste sensation alone, is mediated by a large group of 25 cell surface proteins known as, bitter taste receptors (T2Rs). T2Rs belong to the G-protein coupled receptor (GPCR) superfamily. However, they share little homology with the large subfamily of Class A GPCRs. Very little progress has been made in understanding the dynamics of T2R activation, and in discovery of molecules that can block (bitter blockers) T2R activation. Only recently few structure-function studies focused on elucidating the ligand binding mechanisms of T2Rs have been published. Here we will discuss the roles of conserved amino acids in T2R structure-function, possible mechanisms of activation of T2Rs, and compare and contrast with the recent crystal structures of the Class A GPCRs.
Export Options
About this article
Cite this article as:
Prasad Pydi Sai, Upadhyaya Jasbir, Singh Nisha, Pal Bhullar Rajinder and Chelikani Prashen, Recent Advances in Structure and Function Studies on Human Bitter Taste Receptors, Current Protein & Peptide Science 2012; 13 (6) . https://dx.doi.org/10.2174/138920312803582942
DOI https://dx.doi.org/10.2174/138920312803582942 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Prevention of Cardiovascular Diseases with Anti-Inflammatory and Anti- Oxidant Nutraceuticals and Herbal Products: An Overview of Pre-Clinical and Clinical Studies
Recent Patents on Inflammation & Allergy Drug Discovery From Rapid to Delayed and Remote Postconditioning: The Evolving Concept of Ischemic Postconditioning in Brain Ischemia
Current Drug Targets Disrupted White Matter Networks from Subjective Memory Impairment to Amnestic Mild Cognitive Impairment
Current Alzheimer Research Perfect 24-hr Blood Pressure Control: Up-to-Date 2020
Current Hypertension Reviews Adipose Tissue as a Regulator of Energy Balance
Current Drug Targets Polyphenols and Neuroprotection against Ischemia and Neurodegeneration
Mini-Reviews in Medicinal Chemistry Editorial [Hot Topic:The Metabolic Treatment of Coronary Artery Disease and Heart Failure(Executive Editor: Pericle Di Napoli)]
Current Pharmaceutical Design Strategies for Non-Invasive Molecular Imaging of Acute Allograft Rejection by Gamma Scintigraphy and Positron Emission Tomography
Current Radiopharmaceuticals Molecular Imaging of Vascular Thrombosis
Current Molecular Imaging (Discontinued) New Antidiabetic Therapies: A Paradigm Shift in Type 2 Diabetes Management
Current Pharmaceutical Design CYP Epoxygenase Derived EETs: From Cardiovascular Protection to Human Cancer Therapy
Current Topics in Medicinal Chemistry Protein Aggregation in Neurodegenerative Diseases: Insights from Computational Analyses
Current Bioinformatics Micro RNA: An Epigenetic Regulator of Type 2 Diabetes
MicroRNA Impact of Tracer Retention Levels on Visual Analysis of Cerebral [<sup>18</sup>F]- Florbetaben Pet Images
Current Radiopharmaceuticals Cellular Receptors of Extracellular Matrix Molecules
Current Pharmaceutical Design The Role of Exhaled Nitric Oxide in the Diagnosis, Management and Treatment of Asthma
Mini-Reviews in Medicinal Chemistry Synthesis and SARs of Coumarin Fused 1,5-Benzothiazepines as Novel Anticancer and Antioxidant Agents
Mini-Reviews in Organic Chemistry Novel Strategies to Ameliorate Radiation Injury: A Possible Role for Tetrahydrobiopterin
Current Drug Targets Editorial [Hot Topic:The Search for Novel Anti-Thrombotic Drug Targets (Executive Editor: Dermot Cox)]
Current Pharmaceutical Design Total Bakkenolides Protects Neurons Against Cerebral Ischemic Injury Through Inhibition of Nuclear Factor-κB Activation
CNS & Neurological Disorders - Drug Targets